Overview of Poster Sessions
Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
POSTER SESSION I, SUNDAY, FEBRUARY 2, 2003
Basic Neuroscience
P1. Chronic fatigue syndrome: quantitative single-voxel 1H MR spectroscopy of the basal ganglia. G Andrews, K Sleigh, B Forster, G Stiver, A Chow, B Maedler, A MacKay, S Isserow
P2. Creation of teaching materials to promote transfer of neuroanatomical knowledge from classroom to bedside. RA Hurley, LA Hayman, KH Taber
P3. The neural connectivity of the retrosplenial cingulate cortex. J Parvizi, G Van Hoesen, JV Buckwalter, E Vianna
P4. Ethanol-induced reduction of CREB activity and BDNF production in human neuroblastoma SH-SY5Y cells. T Saito, R Sakai, H Sohma, H Ikeda, M Yamamoto, Y Kuroki
General Clinical Neuropsychiatry
P7. Detecting adverse drug events in neuropsychiatric care. JJ Campbell, CE Coffey, M Boyle, C Ludwicki, R Gafka
P8. A controlled study of the association of older age with depression and anxiety in HIV-1 infection. K Goodkin, I Khamis, D Lee, R Lecusay, P Suarez, FL Wilkie, M Concha, S Symes
P9. Effects of nicotine on eye movement during visual attentional performance. H Ikeda, Y Hatakeyama, H Tominaga, H Miura, R Sasaki, T Saito
P10. Impairment in social cognition following lesions of ventromedial and dorsolateral prefrontal cortex. LWY Mah, MC Arnold, J Grafman
P11. Anxiety, sensitivity, cognition, and coping strategies in panic disorder patients with and without agoraphobia. N Minamikawa, T Iketani, K Nagao, A Shidao, H Fukuhara, M Katagami, N Kiriike
P12. Motor and cognitive symptoms are associated with depression in preclinical Huntington's disease. C Nehl, K Ferneybough, B McDowell, J Paulsen*
P14. Cognitive and somatic symptoms of depression in at-risk individuals and symptomatic Huntington's disease patients. K Ferneybough, C Nehl, B McDowell, JS Paulsen*
P15. The effect of early versus late antidepressant treatment on physical impairment associated with poststroke depression: a time-related therapeutic window. K Narushima, RG Robinson
P16. Slow-frequency rTMS reduces fibromyalgia pain. SM Sampson, JD Rome, TA Rummans
P17. Improvement of cognitive function associated with olanzapine in the treatment of acute mania. L Shi, LM Schuh, LX Huang, MG Wilson, MA Namioshil, RW Baker, PT Trzepacz, M Tolien
P18. Spanish-English issues in the psychiatric assessment of Axis I disorders in HIV-1 seropositive individuals. P Suarez, K Goodkin, A Ardila, FL Wilkie, M Concha, D Lee, R Lecusay, S O'Mellan
P19. Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis. CA Wall, TA Rummans, AJ Aksamit, VS Pankratz
P20. Divalproex decreases impulsivity in compulsive gamblers. JA Wilcox
P21. Aggression induced by interferon alfa-2b during long-term therapy for chronic hepatitis. NW Withers
P22. Right lenticular lacunar infarction and delusion: a case report. K Yoshiyama, T Nishikawa, Y Ikejiri, H Kazui, H Tokunaga, S Tamenaga, M Takeda
Neuroimaging
P23. A group-averaged structural MRI study of Tourette syndrome. CF Black, JM Hartlein, T Hershey, JS Perlmutter, KJ Black*
P24. Abnormal dopamine-mediated brain function in Tourette syndrome revealed by cognitive-pharmacologic fMRI. T Hershey, KJ Black*, JM Hartlein, DM Barch, TS Braver, JL Carl, JS Perlmutter
P25. The relationship between multiple sclerosis and major depression clarified: an MRI brain segmentation study. L Chamellan, A Feinstein*, P Roy, N Lobaugh, K Feinstein, P O'Connor, S Black
P26. Reduced superior temporal gyrus volumes in bipolar disorder. GE Getz, DE Fleck, ME Zimmerman, M Schwiers, MP DelBello, SM Strakowski
P27. Right frontal white and gray matter volumes correlate with depressive symptoms in MS. BA Greenlee, HA Wishart, BC McDonald, JJ Randolph, CE Fadul, LH Kasper, KA Ryan, TW McAllister, AJ Saykin
P28. Neural substrates of emotional habituation: a PET study. N Hatta, Y Masaki, D Talant, A Ogino, N Miyoshi, H Tokunaga, H Kazui, Y Ikejiri, T Uema, T Nishikawa, N Oku, M Takeda
P29. Acquired brain injury: amount of tissue loss, not etiology, alters cognitive and emotional function. RO Hopkins, D Tate, ED Bigler
P30. A case with a transient lesion in the splenium of the corpus callosum caused by antiepileptic drug. H Narita, T Odawara, C Kawanishi, I Kishida, E Iseki, K Kosaka
P31. An fMRI study of brain activation during implicit learning in obsessive-compulsive disorder. RM Roth, AJ Saykin, HA Wishart, LA Flashman, J Ward, AC Mamourian
P32. Functional neuroanatomy of obsessive-compulsive hoarding. S Saxena, K Maidment, EC Smith, N Zohrabi, ML Ho, AL Brody, LR Baxter, Jr.
P33. Relationship of decreased gray matter volume to verbal learning and subjective memory complaints in healthy older adults and patients with mild cognitive impairment. AJ Saykin, HA Wishart, R Santulli, LA Flashman, LA Rabin, TL McHugh, JS Ramirez, AC Mamourian
P34. Gray matter volume predicts age-related alterations in brain fMRI activation pattern during working memory. HA Wishart, AJ Saykin, BC McDonald, LA Flashman, R Santulli, TL McHugh, KR Schuschu, LA Rabin, AC Mamourian
P35. PET images of emotionally valenced episodic memory. M Yoshihiro, N Hatta, D Talant, A Ogino, N Miyoshi, H Tokunaga, H Kazui, Y lkejiri, T Uema, T Nishikawa, N Oku, M Takeda
Neuropsychology
P36. Longitudinal association between Clinical Dementia Rating and Geriatric Depression Scale scores in mildly cognitively impaired elderly subjects. CE Bromberg, KL Dahlman, W Hirst, J Schmeldler, DB Marin
P37. Alternate-form reliability of five alternate forms for five neuropsychological tests. PS Fastenau
P38. Is the cognitive impairment in isolated subtentorial stroke primarily state dependent? M Hoffmann, F Schmitt, T Carnaby, M Mattingly
P39. High scores on the cognitive difficulties scale reflect neuropsychological performance in HIV-1 infection. D Lee, P Suarez, FL Wilkie, M Concha, S Symes, R Molina, K Goodkin
P40. Huntington's disease and comorbid cocaine abuse: a case study. S Mascoop
P41. Double dissociation of reading routes in focal dementing syndromes. MF Mendez
P42. Anomia in nonfluent primary progressive aphasia. MF Mendez, DG Clark
P43. Semantic dementia in two multilingual patients. MF Mendez, S Saghafi, DG Clark
P44. Directed forgetting effect in obsessive-compulsive disorder. M Hayashi, M Mimura*, K Shishikura, K Kamijia
P45. Measurement of attention in children by use of the NEPSY. JR O'Jile, CE Davis, C Simpson, D Elkin, J Rhudy
P46. Mixed handedness and cognitive abilities in boys. PSB Sarma
P47. Neuropsychological functioning in breast cancer patients prior to systemic therapy in comparison to published norms. A Stewart, B Collins, C Bielajew, E Tomiak
P49. Neural basis for writing familiar and novel letters: a PET study. H Tokunaga, T Nishikawa, Y Ikejiri, H Kazui, N Oku, M Takeda
P50. Relationship of cognitive functioning to antiretroviral medication adherence in HIV-1 infection. FL Wilkie, K Goodkin, M Concha, S Symes, D Lee, P Suarez, R Molina
POSTER SESSION II, TUESDAY, FEBRUARY 4, 2003
Dementia
P51. Severe, refractory depression and the development of a buccofacial movement disorder in a patient with vascular dementia secondary to polycythemia vera: a case study. CL Bishop, HJ Westervelt, RA Stern
P52. A case of apparent progressive cognitive decline in an older woman with multiple treated endocrinopathies: importance of considering endocrine status in diagnosing dementia. JD Davis, RA Stern
P53. The determinants of subjective quality of life in patients with Huntington's disease. JD Duffy, E Doherty, S Bullard, MJ Fitzpatrick, B Hennig, AW Deckel, S Spencer
P54. The neurobehavioral characteristics of patients with early and mid-stage Huntington's disease. S Spencer, JD Duffy*, S Bullard, E Doherty, MJ Fitzpatrick, B Hennig, AW Deckel
P55. Prevalence of depression and anxiety in early and mid-stage Huntington's disease. S Bullard, E Doherty, JD Duffy*, B Hennig, MJ Fitzpatrick, AW Deckle
P56. Relationship between cerebral atrophy and informant-based ratings of dementia participants in the Cache County study. MA Fearing, ED Bigler, KD Garrett, J Tschanz, KA Welsh-Bohmer
P57. Reduction by olanzapine of occupational disruptiveness among caregivers of patients with Alzheimer's dementia. PD Feldman, JS Kennedy, CA Young, DL Kadam, WR Earley, A Breier
P58. Behavioral and psychological symptoms of dementia and ECD-SPECT findings in patients with vascular dementia. H Hashimoto, J Kawabe, T Kai, S Higashiyama, H Mori, S Shiomi, N Kiriike
P59. Performance of Spanish- and English-speaking normal control subjects on the Mattis Dementia Rating Scale. I Hernandez, SA Lyness, EL Teng, HC Chui; presenter: S Padilla
P60. Alteration of regional cerebral glucose metabolism with delusional misidentification syndrome in Alzheimer's disease. Y Ikejiri, M Hashimoto, E Mori, K Ishii, N Hirono, T Nishikawa, M Takeda
P61. The concentrations of serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol in Japanese sporadic Alzheimer's disease. T Ishizuka, S Higashi, H Baba, K Eto, H Arai
P62. Clinicopathological and neurochemical study of two subtypes of Pick's disease in Japan. T Odawara, E Iseki, K Shiozaki, T Aral, K Kosaka
P63. Donepezil provides significant benefits in patients with vascular dementia. CA Perdomo, RD Pratt, donepezil 307 and 308 VaD Study groups
P64. A double-blind study of thyroxine in the treatment of Alzheimer's dementia. RA Stern, JD Davis, BL Rogers, KM Smith, CJ Harrington, BR Ott, AJ Prange Jr.
P65. Thyroid hormone concentrations in prefrontal cortex of postmortem brains of Alzheimer's disease patients and control subjects. A Podolanczuk, JD Davis, E Stopa, JV Hennessey, L-G Luo, Y-P Lim, RA Stern
P66. A meta-analysis of neuropsychologic, neuroanatomic, and APOE genotype changes in preclinical Alzheimer's disease. KK Zakzanis, MI Boulos
P67. Cognitive and MRI findings in an autopsy-confirmed case of Pick's disease nine years prior to death. RF Zec, M Ghobrial, Z Wang, T Ala, GY Pyo, R Elble
Schizophrenia
P68. Practice effects of serial neuropsychological testing in patients with schizophrenia and healthy volunteers. S Ahmed, L Beglinger, O Tangphao-Daniels, M Derby, E Siemers, DA Kareken
P69. Quantitative analysis of nitric oxide synthase and guanilate cyclase in schizophrenia brain. H Baba, H Arai
P70. Late postnatal sprouting of amygdalocortical projections targeting the GABAergic interneuron. MG Cunningham, S Bhattacharyya, FM Benes
P71. Apathy and neuropsychological functioning in schizophrenia. LA Flashman, RM Roth, AJ Saykin, T McAllister, R Vidaver
P72. Neurocognition and long-term prediction of quality of life in schizophrenia. DE Fujii, AM Wylie, J Nathan
P73. Diminished flexibility of central nervous system in never-medicated schizophrenia: EEG analysis during intermittent photic stimulation. M Kikuchi, Y Koshino
P74. Global CAG repeat profiles in psychiatric patients with and without tardive dyskinesia: a pilot study. P Lowrimore, Y-H Wang, A Epstein, D Mulvehill, M McCormack
P75. A comparative profile analysis of neuropsychological functioning in schizotypal personality disorder and schizophrenia. M Matsui, T Sumiyoshi, K Kato, E Y, M Kurachi
P76. Reduced EEG coherence during photic stimulation in paranoid schizophrenia with acute exacerbation: longitudinal stability and relationship to symptom change. T Nagasawa, M Kikuchi, T Takeda, T Oka, M Kitamura, N Hirao, M Higashima, Y Koshino
Traumatic Brain Injury
P78. Cholinesterase inhibition after discrete basal forebrain injury. JC Adair
P79. Apolipoprotein E4 in association with persistent neurophysiologic impairment after mild traumatic brain injury. DB Arciniegas, JL Topkoff, CM Filley, LE Adler, CA Anderson, KA Ricketts, EB Spector
P80. Clinical rating of cortical atrophy and cognitive correlates following traumatic brain injury. AG Bergeson, R Lundin, RB Parkinson, DF Tate, J Victoroff, RO Hopkins, ED Bigler*
P81. Neuropsychological, psychiatric, and demographic factors relate to postconcussion symptom reporting after traumatic brain injury. KS Comins, LM Ryan, MB Sparling, DL Warden
P82. The combination of dopamine agonists and mood stabilizers in traumatic brain injury. Z Chemali
P83. Characteristics of a group of military traumatic brain injury patients with somatoform symptoms. LM French, LM Ryan, D Warden
P84. A comparison of neuropsychological functioning in psychotic disorder following traumatic brain injury, traumatic brain injury without psychosis, and schizophrenia. DE Fujii, I Ahmed
P85. MMSE scores among traumatic brain injury patients admitted for acute rehabilitation. BD Jordan, K Ortega-Verdejo
P86. Differential activation of working memory-associated frontal cortex using a dopamine agonist after mild traumatic brain injury (MTBI). TW McAllister, LA Flashman, PK Shaw, RB Ferrell, HA Wishart, BC McDonald, AC Mamourian, JS Ramirez, AJ Saykin
P87. Prediction of return to work after treated mild traumatic brain injury. CE Paniak, G Toller-Lobe, J Nagy
P88. The relationship of apathy to executive functioning and frontal lobe lesions in TBI. LM Ryan, TD Maryniak, MB Sparling, KS Comins, J Smirniotopolis, DL Warden
P89. Remote evaluation of postconcussion symptoms utilizing telemedicine technology. MB Sparling, KS Comins, LM Ryan, RJ Labutta, DL Warden
P90. Use of the Modified 2×3 Test to assess executive functioning in traumatic brain injury. MA Struchen, L Rosas
P91. Phenomenology and course of stress-related symptoms one month and one year after mild traumatic brain injury (MTBI). KS Tanev, LA Flashman, AJ Saykin, TW McAllister
P92. Pathological laughing and crying following traumatic brain injury. A Tateno, RE Jorge, RG Robinson
P93. Clinical characteristics of posttraumatic stress disorder after traumatic brain injury. A Tateno, RE Jorge, RG Robinson
P94. Association of PTSD with comorbid psychiatric disorders and outcome after traumatic brain injury. DL Warden, MB Sparling, LM Ryan, E Moy-Martin
Other Topics
P95. Comparison of psychiatric symptoms in patients with hepatitis C, human immunodeficiency virus, and co-infection. RC Hilsabeck, MD Carlson, EA Ziegler, DL Oliver, C Mathews, TI Hassanein, W Perry
P96. Effects of nutrients on enhanced rebound hyperphagia induced by maternal separation and/or space restriction stress. S Iwasaki, K Inoue, K Hikiji, K Ichihara, A Nakada, T Muramatsu, N Kiriike
P97. Diminished flexibility of central nervous system in never-medicated panic disorder: quantitative EEG analysis. T Kidani, M Kikuchi, R Komuro, H Oka, A Hanaoka, Y Koshino
P98. Greater homozygosity on the Huntington's disease gene in persons with tardive dyskinesia. P Lowrimore, Y-H Wang, A Epstein, D Mulvehill, M McCormack
P99. Brain activation patterns in frontal and temporal memory circuitry following temporal lobe resection for intractable epilepsy: an fMRI study. BC McDonald, AJ Saykin, BC Jobst, PD Williamson, DW Roberts, VM Thadani, JD Schoenfeld, HA Wishart, LA Flashman, TW McAllister
P100. Beneficial effects of quetiapine treatment in patients with fibromyalgia. M Shemo, JPD Shemo, M Anderson
P101. Reversal of the ERP old/new effect during word recognition in a patient with amnesia. MI Boulos, KK Zakzanis*, AA Ashamalla
Information & Authors
Information
Published In
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 250 - 253
History
Published online: 1 May 2003
Published in print: May 2003
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
PDF/ePub
View PDF/ePubGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).